{
    "clinical_study": {
        "@rank": "15126", 
        "acronym": "CPAP-RFP", 
        "arm_group": [
            {
                "arm_group_label": "CPAP +4 cm H2O", 
                "arm_group_type": "Experimental", 
                "description": "CPAP +4 cm H2O pressure using ResMedTM face mask"
            }, 
            {
                "arm_group_label": "ShamCPAP", 
                "arm_group_type": "Sham Comparator", 
                "description": "shamCPAP using ResMedTM CPAP face mask modified for technical sham"
            }
        ], 
        "brief_summary": {
            "textblock": "The project aims to study whether the application of a continuous positive airway pressure\n      (CPAP) of 4 cm water vapor is a safe method  in pulmonary radiofrequency intervention (PRF)\n      lung cancer under conscious sedation compared with placebo. And, assess whether CPAP\n      prevents atelectasis formation and consequently reduces the potential complications of PRF\n      and improves procedural success"
        }, 
        "brief_title": "Study of the Application of CPAP to Reduce Complications and Improve Lung Cancer Ablation Radiofrequency Treatment", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Atelectasis", 
            "Lung Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Pulmonary Atelectasis", 
                "Lung Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  male and female aged 18 years and older\n\n          -  Patient with a scheduled intervention  for ablation of pulmonary malignant tumor with\n             radiofrequency .\n\n          -  Patient able to undergo tests and examinations required by the study.\n\n        Exclusion Criteria:\n\n          -  Patients with CPAP intolerance test.\n\n          -  Patients with progressive disease in which local treatment is not applicable\n\n          -  Patients with intercurrent process (pleural effusion, pneumonia, ...).\n\n          -  Patient unable to understand the proceedings.\n\n          -  Pregnancy or breastfeeding."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02117908", 
            "org_study_id": "CPAP-RFP"
        }, 
        "intervention": {
            "arm_group_label": [
                "CPAP +4 cm H2O", 
                "ShamCPAP"
            ], 
            "description": "Continuous positive pressure during surgery", 
            "intervention_name": "RESMED AUTOSET S9", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "prevention", 
            "radiofrequency treatment", 
            "lung cancer ablation"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "contact": {
                "email": "svarea@clinic.ub.es", 
                "last_name": "Sara Varea, BS (Biology)", 
                "phone": "+34932275400", 
                "phone_ext": "3343"
            }, 
            "contact_backup": {
                "email": "jaarnaiz@clinic.ub.es", 
                "last_name": "Joan A Arnaiz, MD, PhD", 
                "phone": "+34932275400", 
                "phone_ext": "9838"
            }, 
            "facility": {
                "address": {
                    "city": "Barcelona", 
                    "country": "Spain", 
                    "zip": "08036"
                }, 
                "name": "Hospital Clinic of Barcelona"
            }, 
            "investigator": {
                "last_name": "Enrique J Carrero Cardenal, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Application of CPAP to Reduce Complications and Improve Treatment of Radiofrequency Ablation of Lung Cancer Under Conscious Sedation. A Randomized Study", 
        "overall_contact": {
            "email": "ecarrero@clinic.ub.es", 
            "last_name": "Enrique J Carrero, MD, PhD", 
            "phone": "+34932275400"
        }, 
        "overall_official": {
            "affiliation": "Hospital Cl\u00ednic i Provincial de Barcelona", 
            "last_name": "Enrique J Carrero Cardenal, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients with any of the following complications\nPulmonary over-distention along intervention Pneumothorax along intervention Bronchial fistulas measures Computed tomography (CT)1, CT2 and CT3 Vomiting along intervention Decrease in MAP (mean arterial pressure) > 20% measured in the intraoperative period\nAssay of each of the previous complications", 
            "measure": "Number of Participants with Adverse Events as a Measure of Safety", 
            "safety_issue": "Yes", 
            "time_frame": "thirty days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02117908"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fundaci\u00f3 Cl\u00ednic per la Recerca Biom\u00e8dica", 
            "investigator_full_name": "Sara Varea", 
            "investigator_title": "Clinical Research Manager", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Atelectasic area Normal ventilation pulmonary area Hypoventilation pulmonary area Hyperventilation  pulmonary area Bronchial wall injury distance", 
                "measure": "Prevention of atelectasis.", 
                "safety_issue": "Yes", 
                "time_frame": "during surgery"
            }, 
            {
                "description": "Major complications (death, failure to complete treatment, need for manual ventilation, intubation or resuscitation, pulmonary hemorrhage, need for pleural drainage, shock, fistulas, nerve injury, diaphragmatic injury, persistent pain, infections, increased hospitalization time and readmission rates) and any classified as a serious adverse event.", 
                "measure": "Decrease associated complications with PFR. Measurement times: intraoperative, PACU (post-anesthesic care unit), hospital discharge, day 15 and day 30.", 
                "safety_issue": "Yes", 
                "time_frame": "thirty days"
            }, 
            {
                "description": "Tumor ablation range, measured in CT3.", 
                "measure": "Treatment success", 
                "safety_issue": "No", 
                "time_frame": "Measurement time: CT3"
            }, 
            {
                "description": "Minor complications (transient episodes of hypoxemia, apnea / hypoventilation or hypotension, pneumothorax without clinic symptoms or drainage, increased need for sedation, longer procedure) and any other event  adverse not classified as serious.", 
                "measure": "Predictors factors of the occurrence of complications during PRA (pulmonary radiofrequency ablation).", 
                "safety_issue": "Yes", 
                "time_frame": "thirty days"
            }
        ], 
        "source": "Fundacion Clinic per a la Recerca Biom\u00e9dica", 
        "sponsors": {
            "collaborator": {
                "agency": "Spanish Ministry of Economy and competitivity", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Sara Varea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}